{"created":"2021-03-01T06:20:45.923360+00:00","id":16192,"links":{},"metadata":{"_buckets":{"deposit":"c9a8191c-b0b6-4cdb-a543-ad9e77cdaa22"},"_deposit":{"id":"16192","owners":[],"pid":{"revision_id":0,"type":"depid","value":"16192"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00016192","sets":["453:456","471:537:538:1099"]},"item_7_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"4)The Genetic Diagnosis for Gynecological Diseases"}]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1999-02","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"98","bibliographicPageStart":"94","bibliographicVolumeNumber":"113","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Approximately 5－10％ of breast and ovarian cancer cases are due to an inherited susceptibility. The majority of inherited and ovarian cancers. unceptibillity is due to reputations in the BRCA 1 and BRCA 2 genes, however, other genes responsible for inherited susceptibility to these diseases are yet to be identified. Genetic testing for inherited cancer susceptibility will play an increasingly important role in health care. Providing accurate cancer, risk assessment and identifying appropriate individuals for genetic testing for cancer susceptibility mutations can lead to improve strategies for screening and prevention methods. Genetic testing for inherited cancer susceptibility can affect an individual’s personal, medical, psychological, familial, social, ethical and financial well－being, however, the benefits and longterm effects of this testing are not yet clear. It is therefore prudent for all health care professionals to follow published guidelines and recommendations for providing testing for inherited cancer susceptibility to ensure informed consent and minimize harm to individuals and their families","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"103293","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Aida, Hiroshi"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"相田, 浩"}],"nameIdentifiers":[{"nameIdentifier":"103292","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-07"}],"displaytype":"detail","filename":"113(2)_94-98.pdf","filesize":[{"value":"984.4 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"113(2)_94-98.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/16192/files/113(2)_94-98.pdf"},"version_id":"a7c0ffce-6099-442c-b9d6-92bee4c298e1"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"The genetic diagnosis","subitem_subject_scheme":"Other"},{"subitem_subject":"BRCA 1","subitem_subject_scheme":"Other"},{"subitem_subject":"Familial breast－ovarian cancer","subitem_subject_scheme":"Other"},{"subitem_subject":"遺伝子診断","subitem_subject_scheme":"Other"},{"subitem_subject":"家族性乳癌卵巣癌","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"4）産婦人科疾患における遺伝子診断（シンポジウム 遺伝子診断の最近の進歩, 第541回新潟医学会 ）","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"4）産婦人科疾患における遺伝子診断（シンポジウム 遺伝子診断の最近の進歩, 第541回新潟医学会 ）"},{"subitem_title":"4）産婦人科疾患における遺伝子診断（シンポジウム 遺伝子診断の最近の進歩, 第541回新潟医学会 ）","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1099"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-02-17"},"publish_date":"2017-02-17","publish_status":"0","recid":"16192","relation_version_is_last":true,"title":["4）産婦人科疾患における遺伝子診断（シンポジウム 遺伝子診断の最近の進歩, 第541回新潟医学会 ）"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:47:47.179388+00:00"}